Mylan Tries To Escape Pharmacy's EpiPen Antitrust Suit

By Meghan Kelly · December 15, 2020, 5:46 PM EST

Mylan Pharmaceuticals has urged a Kansas federal judge to drop it from a suit alleging it inflated the price for the emergency allergy medication EpiPen, arguing the retail and online pharmacy...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation

Case Number

2:17-md-02785

Court

Kansas

Nature of Suit

Personal Inj. Prod. Liability

Date Filed

August 04, 2017

Case Title

KPH Healthcare Services, Inc. v. Mylan N.V. et al

Case Number

2:20-cv-02065

Court

Kansas

Nature of Suit

Anti-Trust

Date Filed

February 14, 2020

Featured Stories

3 Takeaways From 6th Circ. ERISA Disability Benefits Revival No Photo Available

Kellie Mejdrich

A recent Sixth Circuit ruling that handed a worker a new shot at long-term disability benefits gives a boost to plaintiffs battling ca... (more story)

W.Va. Amendment Marks Obstacle For Aid-In-Dying Movement No Photo Available

Gianna Ferrarin

A first-of-its-kind prohibition in West Virginia on medically assisted suicide represents a new form of opposition to a growing moveme... (more story)

Congress' Dash For Telehealth Extensions: 4 Things To Know No Photo Available

Mark Payne

With Republicans set to take control of Congress and the White House, lame-duck lawmakers on Capitol Hill are in a mad dash to pass le... (more story)